Arich Enterprise Co., Ltd. (TPEX:4173)
Taiwan · Delayed Price · Currency is TWD 20.60
-0.05 (-0.24%)
Apr 2, 2026, 1:30 PM CST
Arich Enterprise Revenue
In the year 2025, Arich Enterprise had annual revenue of 1.55B TWD with 19.20% growth. Arich Enterprise had revenue of 406.74M in the quarter ending December 31, 2025, with 19.23% growth.
Revenue
1.55B
Revenue Growth
+19.20%
P/S Ratio
0.99
Revenue / Employee
7.81M
Employees
198
Market Cap
1.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.55B | 249.23M | 19.20% |
| Dec 31, 2024 | 1.30B | 157.69M | 13.83% |
| Dec 31, 2023 | 1.14B | 122.06M | 11.99% |
| Dec 31, 2022 | 1.02B | 72.36M | 7.65% |
| Dec 31, 2021 | 945.66M | -305.73M | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Cowealth Medical Holding | 2.96B |
| Bioptik Technology Incorporation | 837.19M |
| Tien Liang BioTech | 511.79M |
| GenMont Biotech Incorporation | 401.23M |
| InnoPharmax | 55.77M |